Latest Breaking News On - Associate professor jenkins - Page 1 : comparemela.com
$411M Pledged for Researchers to Realize Discoveries
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Advanced Immunotherapy Treatment Shows Promise for Children with Brain Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Fluorescence labelling of distinct layers of the brain. Each colour represents a different cell type within the cortex. view more
Credit: Maria Bergamasco, WEHI.
A novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma.
Using specifically designed receptors, researchers were able to completely clear brain cancer tumours in preclinical models, using chimeric antigen receptor (CAR) T cell therapy.
Published today in
Clinical & Translational Immunology and led by Associate Professor Misty Jenkins, the research is a crucial step towards developing new immunotherapy treatments for this devastating illness.
Novel approach to immunotherapy design could pave the way for new brain cancer treatments
A novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma.
Using specifically designed receptors, researchers were able to completely clear brain cancer tumors in preclinical models, using chimeric antigen receptor (CAR) T cell therapy.
Published today in
Clinical & Translational Immunology and led by Associate Professor Misty Jenkins, the research is a crucial step towards developing new immunotherapy treatments for this devastating illness.
More than 1800 Australians are diagnosed with brain cancer every year. Brain cancer is the leading cause of cancer death in children and adults under 40. Adults diagnosed with glioblastoma have a five-year survival rate of just five per cent.